Vetter Pharma-Fertigung expands its production capacity and continues to strengthen its position as a leading service provider for the pharmaceutical industry.
New bio-pharmaceutical production facility Ravensburg Vetter South (RVS)
Ravensburg/Germany, June 19, 2005 鈥� Vetter Pharma-Fertigung GmbH & Co. KG, the leading expert for aseptic filling of liquid and lyophilized drugs, has announced the expansion of its production capacities for the fall of 2006. The company is presently capable of producing more than 300 million pre-filled syringe systems per year at its separate sites. With it鈥檚 new state-of-the-art facility in the Ravensburg area, Vetter will increase its production capacity by more than 30 percent.
The investment will also boost the Vetter’s product portfolio. The new facility of this internationally active company is being built in the vicinity of the existing production lines. Each location operates independently and can be used at all times as a fully operational back-up facility. By duplicating the production lines, Vetter is providing it’s customers with considerable delivery and process security. For over 15 years, Vetter’s production facilities have been inspected regularly by international regulatory agencies, including the Food and Drug Administration (FDA) from the USA and the European Medicines Agency (EMEA), as well as its customers.
About Vetter Pharma-Fertigung GmbH & Co KG:
Vetter Pharma-Fertigung GmbH & Co. KG has been active as an independent pharmaceutical Service Partner for over 50 years. 25 years ago, Vetter began focusing on the aseptic production of liquid and lyophilized drugs. In addition to standard injection systems and cartridges, Vetter also offers its own administration systems, such as the Vetter Lyo-Ject庐 dual-chamber syringe. This 1,600-strong company has 15 years of experience in working with products and processes approved by the FDA, the EMEA and other authorities. Vetter currently has over 127 patents to its name, including solutions to prevent counterfeiting and piracy. The company acts as a strategic partner for biotech and pharmaceutical companies. Vetter’s Development Service has the expertise to support them in each phase of product development 鈥� from manufacturing to launch. Vetter鈥檚 Commercial Manufacturing handles the entire process, from compounding and aseptic filling to the final packaging of the product. Vetter Solutions鈥� patented application systems excel in the marketplace thanks to their high quality, efficient production processes and patient-friendly designs. This know-how is made available to Vetter partners in Vetter’s production capabilities, offering them a competitive edge in markets throughout the world.